AirSculpt Stock (NASDAQ:AIRS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.69

52W Range

$1.51 - $12.00

50D Avg

$2.33

200D Avg

$4.81

Market Cap

$184.83M

Avg Vol (3M)

$2.79M

Beta

2.27

Div Yield

-

AIRS Company Profile


AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

389

IPO Date

Oct 29, 2021

Website

AIRS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Reportable Segment$151.82M$180.35M

Fiscal year ends in Dec 25 | Currency in USD

AIRS Financial Summary


Dec 25Dec 24Dec 23
Revenue$151.82M$180.35M$195.92M
Operating Income$-11.56M$-1.82M$9.48M
Net Income$-11.67M$-8.25M$-4.48M
EBITDA$1.22M$10.07M$19.74M
Basic EPS$-0.19$-0.14$-0.08
Diluted EPS$-0.19$-0.14$-0.08

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Apr 02, 26 | 8:30 AM
Q3 25Nov 07, 25 | 8:30 AM
Q2 25Aug 01, 25 | 8:30 AM

Peer Comparison


TickerCompany
AMNAMN Healthcare Services, Inc.
CYHCommunity Health Systems, Inc.
DRIODarioHealth Corp.
SIBNSI-BONE, Inc.
PACBPacific Biosciences of California, Inc.
AQSTAquestive Therapeutics, Inc.
INNVInnovAge Holding Corp.
CMPSCOMPASS Pathways plc
OFIXOrthofix Medical Inc.
MLTXMoonLake Immunotherapeutics